189 related articles for article (PubMed ID: 17471182)
1. Population pharmacokinetic modelling of non-linear brain distribution of morphine: influence of active saturable influx and P-glycoprotein mediated efflux.
Groenendaal D; Freijer J; de Mik D; Bouw MR; Danhof M; de Lange EC
Br J Pharmacol; 2007 Jul; 151(5):701-12. PubMed ID: 17471182
[TBL] [Abstract][Full Text] [Related]
2. Influence of biophase distribution and P-glycoprotein interaction on pharmacokinetic-pharmacodynamic modelling of the effects of morphine on the EEG.
Groenendaal D; Freijer J; de Mik D; Bouw MR; Danhof M; de Lange EC
Br J Pharmacol; 2007 Jul; 151(5):713-20. PubMed ID: 17471181
[TBL] [Abstract][Full Text] [Related]
3. Effects of a potent and specific P-glycoprotein inhibitor on the blood-brain barrier distribution and antinociceptive effect of morphine in the rat.
Letrent SP; Pollack GM; Brouwer KR; Brouwer KL
Drug Metab Dispos; 1999 Jul; 27(7):827-34. PubMed ID: 10383928
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic/pharmacodynamic modelling of the EEG effects of opioids: the role of complex biophase distribution kinetics.
Groenendaal D; Freijer J; Rosier A; de Mik D; Nicholls G; Hersey A; Ayrton AD; Danhof M; de Lange EC
Eur J Pharm Sci; 2008 Jul; 34(2-3):149-63. PubMed ID: 18467078
[TBL] [Abstract][Full Text] [Related]
5. Effect of GF120918, a potent P-glycoprotein inhibitor, on morphine pharmacokinetics and pharmacodynamics in the rat.
Letrent SP; Pollack GM; Brouwer KR; Brouwer KL
Pharm Res; 1998 Apr; 15(4):599-605. PubMed ID: 9587957
[TBL] [Abstract][Full Text] [Related]
6. Blood-brain barrier transport and brain distribution of morphine-6-glucuronide in relation to the antinociceptive effect in rats--pharmacokinetic/pharmacodynamic modelling.
Bouw MR; Xie R; Tunblad K; Hammarlund-Udenaes M
Br J Pharmacol; 2001 Dec; 134(8):1796-804. PubMed ID: 11739257
[TBL] [Abstract][Full Text] [Related]
7. Morphine brain pharmacokinetics at very low concentrations studied with accelerator mass spectrometry and liquid chromatography-tandem mass spectrometry.
Sadiq MW; Salehpour M; Forsgard N; Possnert G; Hammarlund-Udenaes M
Drug Metab Dispos; 2011 Feb; 39(2):174-9. PubMed ID: 21059857
[TBL] [Abstract][Full Text] [Related]
8. Impact of efflux transporters and of seizures on the pharmacokinetics of oxcarbazepine metabolite in the rat brain.
Clinckers R; Smolders I; Michotte Y; Ebinger G; Danhof M; Voskuyl RA; Della Pasqua O
Br J Pharmacol; 2008 Dec; 155(7):1127-38. PubMed ID: 18836479
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic-pharmacodynamic modelling of morphine transport across the blood-brain barrier as a cause of the antinociceptive effect delay in rats--a microdialysis study.
Bouw MR; Gårdmark M; Hammarlund-Udenaes M
Pharm Res; 2000 Oct; 17(10):1220-7. PubMed ID: 11145227
[TBL] [Abstract][Full Text] [Related]
10. Effects of quinidine on antinociception and pharmacokinetics of morphine in rats.
Okura T; Morita Y; Ito Y; Kagawa Y; Yamada S
J Pharm Pharmacol; 2009 May; 61(5):593-7. PubMed ID: 19405997
[TBL] [Abstract][Full Text] [Related]
11. In vivo blood-brain barrier transport of oxycodone in the rat: indications for active influx and implications for pharmacokinetics/pharmacodynamics.
Boström E; Simonsson US; Hammarlund-Udenaes M
Drug Metab Dispos; 2006 Sep; 34(9):1624-31. PubMed ID: 16763013
[TBL] [Abstract][Full Text] [Related]
12. Blood-brain barrier transport helps to explain discrepancies in in vivo potency between oxycodone and morphine.
Boström E; Hammarlund-Udenaes M; Simonsson US
Anesthesiology; 2008 Mar; 108(3):495-505. PubMed ID: 18292687
[TBL] [Abstract][Full Text] [Related]
13. Role of P-glycoprotein in the intestinal absorption and clinical effects of morphine.
Kharasch ED; Hoffer C; Whittington D; Sheffels P
Clin Pharmacol Ther; 2003 Dec; 74(6):543-54. PubMed ID: 14663457
[TBL] [Abstract][Full Text] [Related]
14. Modelling of the blood-brain barrier transport of morphine-3-glucuronide studied using microdialysis in the rat: involvement of probenecid-sensitive transport.
Xie R; Bouw MR; Hammarlund-Udenaes M
Br J Pharmacol; 2000 Dec; 131(8):1784-92. PubMed ID: 11139459
[TBL] [Abstract][Full Text] [Related]
15. Blood-brain barrier equilibration of codeine in rats studied with microdialysis.
Xie R; Hammarlund-Udenaes M
Pharm Res; 1998 Apr; 15(4):570-5. PubMed ID: 9587953
[TBL] [Abstract][Full Text] [Related]
16. Physiologically based pharmacokinetic/pharmacodynamic model for the prediction of morphine brain disposition and analgesia in adults and children.
Verscheijden LFM; Litjens CHC; Koenderink JB; Mathijssen RHJ; Verbeek MM; de Wildt SN; Russel FGM
PLoS Comput Biol; 2021 Mar; 17(3):e1008786. PubMed ID: 33661919
[TBL] [Abstract][Full Text] [Related]
17. P-glycoprotein and mutlidrug resistance-associated proteins limit the brain uptake of saquinavir in mice.
Park S; Sinko PJ
J Pharmacol Exp Ther; 2005 Mar; 312(3):1249-56. PubMed ID: 15528451
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic-pharmacodynamic modelling of opioids in healthy human volunteers. a minireview.
Ing Lorenzini K; Daali Y; Dayer P; Desmeules J
Basic Clin Pharmacol Toxicol; 2012 Mar; 110(3):219-26. PubMed ID: 21995512
[TBL] [Abstract][Full Text] [Related]
19. Effect of capillary efflux transport inhibition on the determination of probe recovery during in vivo microdialysis in the brain.
Sun H; Bungay PM; Elmquist WF
J Pharmacol Exp Ther; 2001 Jun; 297(3):991-1000. PubMed ID: 11356921
[TBL] [Abstract][Full Text] [Related]
20. A phase I and pharmacologic study of the MDR converter GF120918 in combination with doxorubicin in patients with advanced solid tumors.
Planting AS; Sonneveld P; van der Gaast A; Sparreboom A; van der Burg ME; Luyten GP; de Leeuw K; de Boer-Dennert M; Wissel PS; Jewell RC; Paul EM; Purvis NB; Verweij J
Cancer Chemother Pharmacol; 2005 Jan; 55(1):91-9. PubMed ID: 15565444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
